About
Personalized Cancer Diagnostics & Treatment
Areas of Focus
Categories
DiagnosticsMiddle East
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
11,350
By Status
SUSPENDED: 1RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT04219475Lead Sponsor
Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
N/ASuspended
1,000 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2025
NCT05736029Lead Sponsor
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
N/ARecruiting
350 participants
Started: Nov 7, 2022 · Completed: Jun 30, 2028
NCT04056247Lead Sponsor
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
N/AActive, not recruiting
10,000 participants
Started: Oct 1, 2019 · Completed: Oct 1, 2029
Funding History (1)
D
Feb 9, 2024
Locations (1)
Headquarters
Binyamina, Israel
Map
Loading map...